Drug Development for Women

By Vanaja V. Ragavan

Drug Development for Women provides a comprehensive review and analyzes the scientific and social environments associated with developing drugs for women related to all aspects of their reproductive life cycle from puberty to old age. Such a text is long overdue. The demand for action in women's health research and practice in many countries, as well as the poor standards of information in some areas, makes a compelling case for this book. The issues covered include: Women in clinical trials: protection or inclusion? Historical perspectives on the development of reproductive drugs Market research and demographic forces Legal issues in drug development and marketing Principles and practice of drug development in contraception and reproductive disease Health care issues during the post reproductive years, including sections on menopause and cardiovascular disease Comprehensive and rationally collated appendices of marketed drugs and drugs in development, which will be a valuable resource for readers This book is essential reading for all those working in the areas of pharmaceutical development, regulatory agencies, medicine, nursing and pharmacy, and also for allied health professionals, physicians, legal and ethical organizations and university- and community-based women's studies programmes.

• Format: Hardcover
• Language: English
• ISBN: 0471968501
• ISBN13: 9780471968504
• Release Date: August 1998
• Publisher: Wiley
• Length: 496 Pages
• Weight: 1.79 lbs.
• Dimensions: 9.4" x 1.3" x 6.1"